Pharmacokinetics of Cefamandole in Patients with Renal Impairment
AUTOR(ES)
Czerwinski, Anthony W.
RESUMO
Cefamandole pharmacokinetics were investigated in 24 adult males with stable renal function and creatinine clearances of 0 to 139 ml/min. After intramuscular injection of 1.0 g of cefamandole, peak plasma concentrations were achieved between 1 and 2 h. Maximum plasma concentration and drug half-life increased as creatinine clearance decreased; i.e., with normal renal function the half-life was 1.49 ± 0.10 h, and in anephrics the half-life was 11.48 ± 1.91 h. The greatest increase in half-life occurred when the creatinine clearance was less than 20 ml/min. At these levels of renal impairment, there was significant variance in calculated half-life among patients. The maximum urine concentration and rate of cefamandole urinary excretion decreased as renal function declined. Evidence suggesting renal and nonrenal methods of drug elimination is presented. Hemodialysis resulted in increased cefamandole elimination.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352626Documentos Relacionados
- Pharmacokinetics of Cefamandole in Patients with Renal Failure
- Pharmacokinetics of sparfloxacin in patients with renal impairment.
- Pharmacokinetics of Cefamandole in Patients with Normal and Impaired Renal Function
- Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
- Pharmacokinetics of Netilmicin in Patients with Renal Impairment and in Patients on Dialysis
